Literature DB >> 8031728

Studies on IL-2 production and T-cell colony forming unit in patients with chronic renal failure.

S K Ha1, H S Cho, H Y Lee, H S Kim, K H Choi, D S Han, B K Lee, J D Kim.   

Abstract

To elucidate the nature of altered cellular immunity seen in patients with chronic renal failure, the values of interleukin-2 (IL-2), a kind of lymphokine, and T-cell colony forming units were measured in controls (N = 10), predialysis uremic patients (N = 14), patients undergoing chronic hemodialysis (HD, N = 11) and patients on continuous ambulatory peritoneal dialysis (CAPD, N = 9). Dialytic patients were selected as relatively stable cases receiving dialysis for more than 3 months. The duration of dialysis was 25.5 +/- 5.5 months in HD and 14.7 +/- 3.0 months in CAPD groups. The mean age was 30.3 years in the control, 36.1 years in the predialysis, 32.9 years in the HD and 41.1 years in the CAPD groups; all 4 groups showed male predominance. The serum creatinine concentration of each group was 1.2 +/- 0.1 mg/dl in the control, 14.1 +/- 0.9 mg/dl in predialysis, 13.5 +/- 1.3 mg/dl in HD and 14.7 +/- 0.9 mg/dl in CAPD groups. The level of IL-2 in the predialysis group was markedly lower compared to the control, HD and CAPD groups (as 3.1 +/- 0.8 unit vs. 8.8 +/- 2.2 unit, 11.8 +/- 3.0 unit and 14.9 +/- 3.4 unit, respectively, p < 0.05); the difference between the control and dialytic groups was not statistically significant.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8031728      PMCID: PMC4532092          DOI: 10.3904/kjim.1993.8.2.86

Source DB:  PubMed          Journal:  Korean J Intern Med        ISSN: 1226-3303            Impact factor:   2.884


  41 in total

1.  T-rosettes in hemodialysis patients and renal allograft recipients.

Authors:  D P Sengar; D B Hyslop; A Rashid; J E Harris
Journal:  Cell Immunol       Date:  1975-11       Impact factor: 4.868

2.  Immune system to uremia.

Authors:  H Dobbelstein
Journal:  Nephron       Date:  1976       Impact factor: 2.847

3.  Prolonged survival of skin homografts in uremic patients.

Authors:  G J DAMMIN; N P COUCH; J E MURRAY
Journal:  Ann N Y Acad Sci       Date:  1957-03-22       Impact factor: 5.691

4.  Immunological aspects of chronic uremia.

Authors:  C U Casciani; C De Simone; S Bonini; M T Gallucci; G Matteucci; G Valesini; D Meli; C Masala
Journal:  Kidney Int Suppl       Date:  1978-06       Impact factor: 10.545

5.  Analysis of immune status of hemodialyzed adults: association with prior transfusions.

Authors:  B S Bender; J L Curtis; J E Nagel; F J Chrest; E S Kraus; G R Briefel; W H Adler
Journal:  Kidney Int       Date:  1984-10       Impact factor: 10.612

6.  Mycobacteriosis in patients with chronic renal failure.

Authors:  E A Rutsky; S G Rostand
Journal:  Arch Intern Med       Date:  1980-01

7.  Tuberculosis in patients undergoing maintenance hemodialysis.

Authors:  A P Lundin; A J Adler; G M Berlyne; E A Friedman
Journal:  Am J Med       Date:  1979-10       Impact factor: 4.965

8.  Humoral inhibitors of the immune response in uremia. V. Induction of suppressor cells in vitro by uremic serum.

Authors:  J Raskova; K Raska
Journal:  Am J Pathol       Date:  1983-05       Impact factor: 4.307

9.  Suppressor cell numbers and activity in non-transfused renal dialysis patients.

Authors:  M D Smith; G Hardy; J D Williams; G A Coles
Journal:  Clin Nephrol       Date:  1983-09       Impact factor: 0.975

10.  Monoclonal antibody directed against interleukin 2. I. Inhibition of T lymphocyte mitogenesis and the in vitro differentiation of alloreactive cytolytic T cells.

Authors:  S Gillis; A E Gillis; C S Henney
Journal:  J Exp Med       Date:  1981-09-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.